Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05687136
Title Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and M1774 for Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
National Cancer Institute Developmental Therapeutics Clinic RECRUITING Bethesda Maryland 20892 United States Details
National Institutes of Health Clinical Center SUSPENDED Bethesda Maryland 20892 United States Details
Massachusetts General Hospital Cancer Center RECRUITING Boston Massachusetts 02114 United States Details
Dana-Farber - Harvard Cancer Center LAO RECRUITING Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
NYU Langone Hospital - Long Island RECRUITING Mineola New York 11501 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone RECRUITING New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field